SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-23-000018
Filing Date
2023-05-04
Accepted
2023-05-04 16:41:21
Documents
110
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20230331.htm   iXBRL 10-Q 2662879
2 EX-10.1 exhibit101formofpsuagreeme.htm EX-10.1 157933
3 EX-31.1 exhibit311q12023.htm EX-31.1 10185
4 EX-31.2 exhibit312q12023.htm EX-31.2 10215
5 EX-32.1 exhibit321q12023.htm EX-32.1 6669
6 EX-32.2 exhibit322q12023.htm EX-32.2 6721
  Complete submission text file 0000885590-23-000018.txt   13180180

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20230331.xsd EX-101.SCH 94136
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20230331_cal.xml EX-101.CAL 87322
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20230331_def.xml EX-101.DEF 567060
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20230331_lab.xml EX-101.LAB 959514
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20230331_pre.xml EX-101.PRE 732437
104 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20230331_htm.xml XML 2474244
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 23889530
SIC: 2834 Pharmaceutical Preparations